Invitation to Presentation of Immunovia’s Interim Report January – June 2021
LUND (SWEDEN) – Immunovia will publish the company’s interim report for the period January 1 – June 30, 2021 on Thursday, August 19, 2021 at 16:00 CEST. Investors, analysts and media are invited to a telephone conference with web presentation on the same day at 16:30 CEST. CEO Patrik Dahlen will present Immunovia and comment on the interim report. Medical Director Dr. Thomas King, Sr. Marketing Director US Cindy Callahan and CEO Patrik Dahlen will also provide an update about the marketing plans following the launch of the IMMRay[TM] PanCan-d test. The presentations will be held in